top of page
Aducanumab: Panacea or Risk for Adults with Down Syndrome

Aducanumab: Panacea or Risk for Adults with Down Syndrome

Conference presentation

​

Virtual presentation on intellectual disability and possible application of aducanumab to
the ACCSES organization on August 5, 2021

bottom of page